Skip to main content
. 2015 Sep 22;10(9):e0138054. doi: 10.1371/journal.pone.0138054

Fig 4. Masson’s Trichrome stained representative sections near implants site taken from POD 12, Masson’s Trichrome (magnification 10x, black scale bars = 100 μm).

Fig 4

(A) Saratin/Ilomostat; (B) Saratin/Bevacizumab/Ilomostat; (C) BSS; (D) MMC (all representative, come from areas of roughly the same location in relation to tube placement)